In the US, it's a free market. Drug companies can price their drugs at whatever price they want. And these, when they came on the market as diabetes drugs, they were priced fairly high. Some of the pricing, there's one that will go V-drug, which is a higher dose version of Zempic that no one nor does sell sort of obesity. They price that at even higher price than a Zempic. It's exact, different doses of the exact same chemical compound, but one is a higher price. The obesity one is ahigher price. But why don't you come out with really cheaper versions of these drugs and lots of people will take them and
Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek."
Hosted by Carol Massar and Madison Mills
Hear the show live at 3PM ET on WBBR 1130 AM New York, Bloomberg 106.1 FM Boston, Bloomberg 960 AM San Francisco, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 119, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio.
You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News.
Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno @MadisonMills22 and @BW
See omnystudio.com/listener for privacy information.